Syngene, BIRAC sets up CAPS lab in Bengaluru under National Biopharma Mission

Syngene, BIRAC sets up CAPS lab in Bengaluru under National Biopharma Mission

India’s leading contract research organization (CRO) Syngene International Ltd has on Friday (05th April) opened a Centre for Advanced Protein Studies (CAPS) at its campus in Bengaluru. The Centre, inaugurated by Renu Swarup, secretary, Department of Biotechnology, Government of India, has been set up in collaboration with the Biotechnology Industry Research Assistance Council (BIRAC) under the National Biopharma Mission announced by the government.

Syngene’s Centre for Advanced Protein Studies will host a modern GLP accredited analytical laboratory. Since regulatory approval of complex biological molecules involves extensive and advanced analytics, including assessment of physiochemical characteristics, efficacy, immunogenicity (antidrug antibody), contamination, strength and more, they need to be performed in a GLP compliant analytical facility. As Indian start-ups and small and medium research companies and the academia often face the challenge of non-availability of appropriate certified facilities at affordable costs, this lab in India is expected to be of immense help to them.

“CAPS will help address this challenge and will be a big boost in advancing biopharma research and product development in India,” the company claimed in a press statement on Friday.

Spread across an area of 2000 sq. ft, the Centre will run under the ‘Innovate in India’ program of the National Biopharma Mission (NBM), Department of Biotechnology, announced by the Government of India. NBM is an industry-academia collaborative mission of the Department of Biotechnology (DBT) and World Bank for accelerating early development of biopharmaceuticals and is being implemented by BIRAC.

“In the last few years, India’s biotechnology sector has seen tremendous action. India has immense scientific and entrepreneurial talent available in the country which gives it strong potential to emerge as the R&D hub for the global biotechnology industry,” said Kiran Mazumdar Shaw, Managing Director, Syngene International in the media statement.

“The CAPS facility will provide the right ecosystem for this talent to pursue their research objectives,” she added.

According to Jonathan Hunt, Chief Executive Officer, Syngene International, the collaboration with BIRAC to set up this facility is indeed an honour for Syngene.

“As India’s largest scientific services provider, this collaboration will help Syngene play an active role in the development of India’s biotechnology industry as well as nurture the innovative spirit within the industry,” he said.

The company said that, apart from providing the necessary infrastructure support at affordable cost, CAPS will also focus on advancing technical skill development to global standards, by conducting various trainings and workshops involving eminent subject experts.

Straight Talk

View More